Stockscreener 앱 받기
0.8649
8.48%
-0.0801
시간 외 거래:
.88
0.0151
+1.75%
Rein Therapeutics Inc 주식(RNTX)의 최신 뉴스
Rein Therapeutics (RNTX) Slips 1.6% as Stock Tests Key Support at $0.89Small Cap Breakouts - newsline.com
RNTX Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Stock HigherPost-Earnings Reaction - newsline.com
Rein Therapeutics enrolls 16 patients in lung fibrosis trial - Investing.com
Rein Therapeutics Expands Phase 2 RENEW Clinical Trial Into United Kingdom - marketscreener.com
RNTX Q1 2026 Earnings: Significant EPS Beat Highlights Cost Discipline as Pre-Revenue Biotech Advances PipelineInterim Report - newsline.com
Rein Therapeutics (NASDAQ: RNTX) 2026 proxy outlines share boost, director elections, pay - Stock Titan
RNTX Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
H.C. Wainwright cuts Rein Therapeutics stock price target on dilution By Investing.com - Investing.com Canada
H.C. Wainwright Maintains Rein Therapeutics(RNTX.US) With Buy Rating, Cuts Target Price to $8 - Moomoo
Rein Therapeutics (RNTX) Holds Steady at $1.11 as Stock Tests Key Support and Resistance LevelsDeath Cross - The Legal Advocate
Rein Therapeutics (RNTX) Holds Steady at $1.11 – Range-Bound Action Points to Key LevelsPCR Mean Reversion - The Legal Advocate
Rein Therapeutics (RNTX) Holds Steady at $1.11 Amid Low Volume ConsolidationBollinger Walk - newsline.com
Rein Therapeutics director buys $49,560 in company stock By Investing.com - Investing.com Australia
Rein Therapeutics director buys $49,560 in company stock - Investing.com
Rein Therapeutics (RNTX) asks shareholders to double authorized shares to 200M - Stock Titan
Rein Therapeutics (RNTX) Slips Near Support; Key Levels TestedVOLD Alert - newsline.com
RNTX Q1 2026 Earnings: EPS Beats Estimates as Preclinical Stage Biotech Tightens SpendingAnalyst Consensus Shift - Newser
RNTX Q1 2026 Earnings: Narrowed Loss Beats Estimates as Rein Therapeutics Advances PipelineProfit Growth Outlook - Newser
RNTX Q1 2026 Earnings: Narrower‑than‑expected Loss Fails to Lift SharesEarnings Acceleration Picks - newsline.com
Rein Therapeutics (RNTX) Surges 7% as Stock Tests Key Resistance at $1.09Community Risk Signals - newser.com
Rein Therapeutics (RNTX) Q1 2026 Earnings Surprise: EPS $-0.19, Up SignificantHigh Estimate Range - Newser
Rein Therapeutics closes $57.5 million stock offering By Investing.com - Investing.com Nigeria
Rein Therapeutics announces closing of $57.5 million underwritten public offering - marketscreener.com
Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering - TradingView
Rein Therapeutics closes $57.5 million stock offering - Investing.com
Biotech Rein Therapeutics raises $57.5M for lung fibrosis trial - Stock Titan
Rein Therapeutics, Inc. Q1 2026 10-Q Report: Financial Statements, Risk Factors, and Forward-Looking Statements - Minichart
Rein Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Rein Therapeutics, Inc. 1Q 2026: Revenue $0 Net loss $(5.84)M, EPS $(0.19) — 10-Q Summary - TradingView
Rein Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
RNTX Technical Analysis | Trend, Signals & Chart Patterns | REIN THERAPEUTICS INC (NASDAQ:RNTX) - ChartMill
Rein Therapeutics CEO Windsor buys $25,000 in common stock By Investing.com - Investing.com Nigeria
Rein Therapeutics CEO Windsor buys $25,000 in common stock - Investing.com
Rein Therapeutics (RNTX) quarterly results lack key metrics as company navigates strategic positioning, investors await clarityMomentum Score - newser.com
Number of shareholders of Rein Therapeutics, Inc. – NASDAQ:RNTX - TradingView
Rein Therapeutics, Inc. News — NASDAQ:RNTX - TradingView
Should you add Rein Therapeutics (RNTX) to your watchlist today? (Trend Strengthens) 2026-05-08Viral Trade Signals - newser.com
Bios/Cavu investors disclose ~9.99% stake in Rein Therapeutics (RNTX) via preferred conversions - Stock Titan
Lynwood group owns 4.75M Rein Therapeutics (RNTX) shares (6.1%) - Stock Titan
Funicular Funds holds 5.195M shares in Rein Therapeutics (RNTX) — 6.7% - Stock Titan
Rein Therapeutics(RNTX) Stock Options Chain | Quotes & News - Moomoo
L. Lytton reports 4.5M shares in Rein Therapeutics (NASDAQ: RNTX) - Stock Titan
Rein Therapeutics, Inc.Common Stock (Nasdaq:RNTX) Stock Quote - The Chronicle-Journal
Rein Therapeutics Prices $50 Million Public Equity Offering - The Globe and Mail
Rein Therapeutics (NASDAQ: RNTX) raises $50M, funds IPF trial into 2028 - Stock Titan
Rein Therapeutics (NASDAQ: RNTX) to sell 50M shares, nets ~$46.1M - Stock Titan
Rein Therapeutics stock dips after pricing $50M share offering - MSN
RNTX Slides As Rein Therapeutics Stock Tests New Lows - timothysykes.com
RNTX Stock Dips As Traders Weigh Deep Losses And Cash Runway - StocksToTrade
Rein Therapeutics Prices $50 Million Common Stock Offering; Shares Down Pre-Bell - Moomoo
Rein Therapeutics | EFFECT: Others - Moomoo
RNTX Stock Slides As Traders Eye Heavy Losses - timothysykes.com
2.60%
0.94%
자본화:
|
볼륨(24시간):